Kerendia (finerenone) — Coverage Criteria
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Iowa Policy 05.04.97 alerts
Get alerted when Policy 05.04.97 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical necessity criteria for coverage of Kerendia (finerenone) for adults with chronic kidney disease and type 2 diabetes or heart failure, per Blue Cross Blue Shield - Iowa.
Reviewed and revised in June 2026 with a current effective date of August 5, 2026.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.